Get 20% lifetime commission for referring investors to digrin.com
here.
Lyell Immunopharma, Inc. ( LYEL) - Key Metrics
LYEL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.92 | -$1.45 | -$1.46 |
| 2026Q1 | $0 | -$1.10 | -$1.76 | -$1.76 |
| 2025Q4 | $0 | -$8.23 | -$1.89 | -$1.90 |
| 2025Q3 | $0 | -$2.13 | -$1.56 | -$1.57 |
| 2025Q2 | $0 | -$2.89 | -$2.33 | -$2.34 |
LYEL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.83 |
| 2026Q1 | 0% | -4.56 |
| 2025Q4 | 0% | -0.71 |
| 2025Q3 | 0% | -1.91 |
| 2025Q2 | 0% | -0.76 |
LYEL
Price: $13.54
52 week price:
Earnings Per Share: -12.69 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 208634
Market Capitalization: 341.8 million